Deadline nears to file claim in class-action lawsuit over drug Rexulti
Canadians have until August 27 to file claims for a $4.75-million settlement regarding the drug Rexulti.Summary
Canadians have until August 27 to file claims for a share of a $4.75-million class-action settlement involving the antipsychotic medication Rexulti. The settlement, approved by the Quebec Superior Court in November, addresses a national class action against Otsuka Canada Pharmaceutical Inc. and Lundbeck Canada Inc.
The lawsuit covers individuals prescribed Rexulti since February 2017 who subsequently developed compulsive behaviors or impulse-control disorders, such as gambling, shopping, or binge-eating. Lawyers for the affected patients and families noted that the settlement is a compromise and does not constitute an admission of liability by the pharmaceutical companies.
Compensation amounts for claimants vary depending on the severity of the condition, with payouts ranging from approximately $6,500 for mild cases to over $102,000 for more severe instances.
(Source：The Globe and Mail)